Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)

NCT00116935 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
400
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Scandinavian Sarcoma Group